Cecelia Health is a technology company.
Cecelia Health has raised $7.0M across 2 funding rounds.
Cecelia Health has raised $7.0M in total across 2 funding rounds.
# Cecelia Health: High-Level Overview
Cecelia Health is a virtual specialty medical practice, not primarily a technology company, though it leverages technology as a core enabler of its care delivery model.[1][2] Founded in 2009, the company provides virtual chronic care management and patient support programs designed to improve medication adherence and health outcomes for individuals with chronic conditions, particularly cardiometabolic diseases.[1][3] The company serves health plans, employers, health systems, providers, pharmaceutical manufacturers, and medical device companies.[3]
Cecelia Health's core value proposition centers on coordinated, clinically accountable virtual care rather than standalone digital tools or coaching platforms.[4] The company operates a comprehensive care team—including physicians, nurses, registered dietitians, certified diabetes care and education specialists, respiratory therapists, and care coordinators—that delivers medication management, medical nutrition therapy, behavior change support, and real-time clinical interventions.[4] This human-led approach, powered by data analytics, distinguishes Cecelia from purely software-based health platforms.
Cecelia Health was founded in 2009 and is based in New York.[3] The company was formerly known as Fit4D before rebranding to reflect its broader mission in virtual specialty care.[3] Over more than a decade of operation, Cecelia has built relationships with major stakeholders across the healthcare ecosystem—health plans, pharmaceutical organizations, and medical device manufacturers—establishing itself as a trusted partner for managing chronic conditions at scale.[1]
Cecelia Health operates at the intersection of digital health transformation and chronic disease management—two of the most pressing challenges in modern healthcare.[3] The company addresses a critical gap: while digital health tools and wearables have proliferated, patients with chronic conditions remain burdened by fragmented care experiences across disparate apps, providers, and support systems.[1]
The timing is favorable for Cecelia's model. Healthcare systems and payers are increasingly focused on value-based care, medication adherence, and cost reduction, particularly for high-cost cardiometabolic conditions that drive chronic care spending.[6] Cecelia's ability to demonstrate measurable improvements in adherence and health outcomes—validated through clinical studies like the ECLIPSE trial examining digital therapeutics for type 2 diabetes—positions it as a credible partner in this shift.[3]
Rather than competing with technology platforms, Cecelia leverages technology as infrastructure to enable human-centered clinical care at scale. This positions the company within the broader trend of human-in-the-loop digital health, where technology augments rather than replaces clinical judgment and patient relationships.
Cecelia Health's evolution reflects a maturing digital health market that increasingly values clinical outcomes over engagement metrics alone. As healthcare organizations demand evidence-based solutions with measurable ROI, Cecelia's positioning as a virtual medical practice—accountable for clinical results—offers differentiation from consumer-facing wellness apps.
The company's future likely hinges on expanding its clinical footprint across additional chronic conditions, deepening partnerships with pharmaceutical and medical device manufacturers seeking real-world evidence, and continuing to refine its data analytics capabilities to demonstrate value at multiple levels: individual patient, population, customer, and disease state.[5] As healthcare consolidation accelerates and payers seek integrated solutions, Cecelia's ability to operate as a trusted clinical partner—rather than a point solution—may prove increasingly valuable in a fragmented market.
Cecelia Health has raised $7.0M in total across 2 funding rounds.
Cecelia Health's investors include OurCrowd, Rose Tech Ventures, SJF Ventures, Chaim Meir Tessler.
Cecelia Health has raised $7.0M across 2 funding rounds. Most recently, it raised $4.0M Venture Round in September 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2018 | $4.0M Venture Round | OurCrowd, Rose Tech Ventures, SJF Ventures, Chaim Meir Tessler | |
| Aug 1, 2015 | $3.0M Series A | SJF Ventures |